Your browser doesn't support javascript.
loading
Candidates for area under the concentration-time curve (AUC)-guided dosing and risk reduction based on analyses of risk factors associated with nephrotoxicity in vancomycin-treated patients.
Hashimoto, Naoto; Kimura, Toshimi; Hamada, Yukihiro; Niwa, Takashi; Hanai, Yuki; Chuma, Masayuki; Fujii, Satoshi; Matsumoto, Kazuaki; Shigemi, Akari; Kawamura, Hideki; Takahashi, Yoshiko; Takesue, Yoshio.
Affiliation
  • Hashimoto N; Department of Pharmacy, Tokyo Women's Medical University Hospital, 8-1 Kawadacho, Shinjuku, Tokyo 162-8666, Japan.
  • Kimura T; Department of Pharmacy, Tokyo Women's Medical University Hospital, 8-1 Kawadacho, Shinjuku, Tokyo 162-8666, Japan. Electronic address: t.kimura.pharm@gmail.com.
  • Hamada Y; Department of Pharmacy, Tokyo Women's Medical University Hospital, 8-1 Kawadacho, Shinjuku, Tokyo 162-8666, Japan.
  • Niwa T; Department of Pharmacy, Gifu University Hospital, 1-1 Yanagito, Gifu, Gifu 501-1194, Japan.
  • Hanai Y; Department of Pharmacy, Toho University Omori Medical Center, 6-11-1 Omorinishi, Ota, Tokyo 143-8541, Japan.
  • Chuma M; Clinical Trial Center for Developmental Therapeutics, Tokushima University Hospital, 2-50-1 Kuramotocho, Tokushima, Tokushima 770-8503, Japan.
  • Fujii S; Department of Pharmacy, Sapporo Medical University Hospital, 291 Minami 1-jo, Nishi 16-chome, Chuo, Sapporo, Hokkaidou 060-8556, Japan.
  • Matsumoto K; Division of Pharmacodynamics, Keio University Faculty of Pharmacy, 1-5-30 Shibakoen, Minato, Tokyo 105-8512, Japan.
  • Shigemi A; Department of Pharmacy, Kagoshima University Hospital, 8-35-1 Sakuragaoka, Kagoshima, Kagoshima 890-8520, Japan.
  • Kawamura H; Department of Infection Control and Prevention, Kagoshima University Hospital, 8-35-1 Sakuragaoka, Kagoshima, Kagoshima 890-8520, Japan.
  • Takahashi Y; Department of Pharmacy, Hyogo College of Medicine Hospital, 1-1 Mukogawa, Nishinomiya, Hyogo 663-8501, Japan.
  • Takesue Y; Department of Infection Control and Prevention, Hyogo College of Medicine, 1-1 Mukogawa, Nishinomiya, Hyogo 663-8501, Japan.
J Glob Antimicrob Resist ; 27: 12-19, 2021 12.
Article in En | MEDLINE | ID: mdl-34371241

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vancomycin / Acute Kidney Injury / Anti-Bacterial Agents Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Glob Antimicrob Resist Year: 2021 Document type: Article Affiliation country: Japan Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vancomycin / Acute Kidney Injury / Anti-Bacterial Agents Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Glob Antimicrob Resist Year: 2021 Document type: Article Affiliation country: Japan Country of publication: Netherlands